Bingxian Sha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bingxian Sha has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Gang Huang
Shanghai Key Laboratory of Molecular Imaging, Pudong Gongli Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China
1 shared publication - Haodong Bai
Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China
1 shared publication - Heng Wu
Department of Psychosomatic Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication - Jashin In
Department of Psychosomatic Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China
1 shared publication - Jiaying Yuan
Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China
1 shared publication - Jingjing Li
Shanghai Key Laboratory of Molecular Imaging, Pudong Gongli Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China; Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
1 shared publication
Latest Publications
- 12 June 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 377, 152898
Portulaca oleracea polysaccharide alleviates UVB-induced solar dermatitis in association with macrophage immunomodulation
- 12 June 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 377, 152898
Portulaca oleracea polysaccharide alleviates UVB-induced solar dermatitis in association with macrophage immunomodulation
- Open Access
- 8 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3618
Somatic Symptom Disorder Is Associated with Cough Hypersensitivity and Poor Response to Anti-Reflux Therapy in Patients with Gastroesophageal Reflux-Induced Chronic Cough
Background/Objectives: Gastroesophageal reflux-induced chronic cough (GERC) is a common cause of chronic cough, and a substantial proportion of patients show an inadequate response to standard anti-reflux therapy. Psychological comorbidities, including somatic symptom disorder (SSD), have been increasingly recognized in this population. However, the prevalence and clinical characteristics of SSD in patients with GERC remain unclear. This study aimed to determine the prevalence of SSD in patients with GERC and to characterize the associated clinical and psychological features. Methods: In this prospective observational study, consecutive patients with GERC diagnosed at Tongji Hospital, Shanghai, China, between January 2024 and June 2025 were consecutively enrolled. SSD was assessed using a structured diagnostic interview based on DSM-5 criteria. Patients were categorized into SSD+ and SSD− groups. Clinical and psychological characteristics were compared between groups, and binary logistic regression was performed to identify factors associated with SSD. Results: A total of 215 patients with GERC were included, of whom 22.3% (48/215) were diagnosed with SSD. Compared with the SSD− group, patients with SSD had higher healthcare utilization, poorer response to standard anti-reflux therapy, increased cough sensitivity, poorer cough-related quality of life, and greater psychological distress. Multivariate logistic regression identified increased cough sensitivity and higher anxiety and depression scores as independent factors associated with SSD. Conclusions: SSD is relatively common in patients with GERC and is associated with cough hypersensitivity, poorer response to anti-reflux therapy, and greater psychological burden. These findings suggest that SSD may represent a clinically relevant phenotype of GERC, and patients with coexisting SSD may require more comprehensive psychosomatic assessment and multidisciplinary management.
- 8 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3618
Open AccessSomatic Symptom Disorder Is Associated with Cough Hypersensitivity and Poor Response to Anti-Reflux Therapy in Patients with Gastroesophageal Reflux-Induced Chronic Cough
Background/Objectives: Gastroesophageal reflux-induced chronic cough (GERC) is a common cause of chronic cough, and a substantial proportion of patients show an inadequate response to standard anti-reflux therapy. Psychological comorbidities, including somatic symptom disorder (SSD), have been increasingly recognized in this population. However, the prevalence and clinical characteristics of SSD in patients with GERC remain unclear. This study aimed to determine the prevalence of SSD in patients with GERC and to characterize the associated clinical and psychological features. Methods: In this prospective observational study, consecutive patients with GERC diagnosed at Tongji Hospital, Shanghai, China, between January 2024 and June 2025 were consecutively enrolled. SSD was assessed using a structured diagnostic interview based on DSM-5 criteria. Patients were categorized into SSD+ and SSD− groups. Clinical and psychological characteristics were compared between groups, and binary logistic regression was performed to identify factors associated with SSD. Results: A total of 215 patients with GERC were included, of whom 22.3% (48/215) were diagnosed with SSD. Compared with the SSD− group, patients with SSD had higher healthcare utilization, poorer response to standard anti-reflux therapy, increased cough sensitivity, poorer cough-related quality of life, and greater psychological distress. Multivariate logistic regression identified increased cough sensitivity and higher anxiety and depression scores as independent factors associated with SSD. Conclusions: SSD is relatively common in patients with GERC and is associated with cough hypersensitivity, poorer response to anti-reflux therapy, and greater psychological burden. These findings suggest that SSD may represent a clinically relevant phenotype of GERC, and patients with coexisting SSD may require more comprehensive psychosomatic assessment and multidisciplinary management.